Miyoko Christina Yi - 16 Dec 2021 Form 4 Insider Report for Provention Bio, Inc.

Role: Chief Operations Officer
Signature: /s/ Thierry Chauche
Issuer symbol: N/A
Transactions as of: 16 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 20 Dec 2021, 16:02:56 UTC
Next filing: 20 Jan 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRVB	Stock Option (right to buy)	Award	$0	+150,000		$0.000000	150,000	16 Dec 2021	Common Stock, par value $0.0001	150,000	$5.88	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 16, 2021 the Reporting Person was granted a stock option for 150,000 shares of Common Stock which vests in four equal annual installments commencing on December 16, 2021. Reporting Person was also granted 150,000 stock options under the Issuer's 2020 Inducement Plan with performance-based vesting triggers that will be reported, if and when vested, consistent with the applicable reporting requirements.
F2	The stock options were granted pursuant to the Issuer's 2020 Inducement Plan.

Content

On December 16, 2021 the Reporting Person was granted a stock option for 150,000 shares of Common Stock which vests in four equal annual installments commencing on December 16, 2021. Reporting Person was also granted 150,000 stock options under the Issuer's 2020 Inducement Plan with performance-based vesting triggers that will be reported, if and when vested, consistent with the applicable reporting requirements.

The stock options were granted pursuant to the Issuer's 2020 Inducement Plan.